Autopsy report · NCT01338025

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

“Study was halted for lack of accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 2 years 2 months before it stopped.
• 33 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Sponsor type

University, hospital or other

Conditions

HIV Disease

Interventions

HAART regimen; 3TC or FTC monotherapy

Participants

33

Sites

17

Countries

Argentina, Brazil, Puerto Rico, Thailand, United States

Trials that died the same way

• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (96% match in meaning)
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  “Study stopped due to low accrual.” (91% match in meaning)
• Sorafenib-induced Hand- Foot Skin Reaction Treatment
  “Study was halted due to poor subject accrual.” (90% match in meaning)
• High Dose Rate Brachyablation of Primary Liver Lesions
  “Study was closed due to poor accrual” (88% match in meaning)
• Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
  “Study was terminated due to lack of accrual” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.